Literature DB >> 24906534

[Driving ability with alcohol and drug dependence and schizophrenia].

M Soyka1, S Dittert, S Kagerer-Volk, M Soyka1.   

Abstract

Alcohol and drugs use are of great relevance for driving ability. The number of alcohol-related accidents with injuries in Germany showed a 40 % decline over the past decade (2011: 15,898 including 400 deaths, other drugs 1400). Road surveys indicate the risk of accidents to be high in psychostimulant users but only medium in opioid users. Guidelines for medical and psychological examinations of drunken drivers are given. Alcohol-related questions are the most commonly encountered in medical psychological expert opinions with 51 % followed by drugs and medications with 21 %. The fundamental principles of expert opinions are presented. At last count the proportion of all investigated persons who tested positive was 55 %. In the absence of other health-related limitations, most patients under substitution therapy for opiate addiction are barely impaired in the cognitive functions relevant for driving ability. The database for traffic offences and schizophrenia is much worse. Acute psychotic illness rules out driving ability. In patients with first onset disease this can usually be granted after 1 year of remission from symptoms but in cases of repeated exacerbations longer intervals of 3-5 years are warranted.

Entities:  

Mesh:

Year:  2014        PMID: 24906534     DOI: 10.1007/s00115-013-3993-3

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  27 in total

1.  Alcohol- or drug-use disorders and motor vehicle accident mortality: a retrospective cohort study.

Authors:  Russell C Callaghan; Jodi M Gatley; Scott Veldhuizen; Shaul Lev-Ran; Robert Mann; Mark Asbridge
Journal:  Accid Anal Prev       Date:  2013-02-01

2.  [Mental disorders in the general population : Study on the health of adults in Germany and the additional module mental health (DEGS1-MH)].

Authors:  F Jacobi; M Höfler; J Strehle; S Mack; A Gerschler; L Scholl; M A Busch; U Maske; U Hapke; W Gaebel; W Maier; M Wagner; J Zielasek; H-U Wittchen
Journal:  Nervenarzt       Date:  2014-01       Impact factor: 1.214

3.  Road traffic crashes and prescribed methadone and buprenorphine: a French registry-based case-control study.

Authors:  Philippe Corsenac; Emmanuel Lagarde; Blandine Gadegbeku; Bernard Delorme; Aurore Tricotel; Anne Castot; Nicholas Moore; Pierre Philip; Bernard Laumon; Ludivine Orriols
Journal:  Drug Alcohol Depend       Date:  2011-11-21       Impact factor: 4.492

4.  [Consensus recommendations for the assessment of fitness to drive in cognitively impaired patients].

Authors:  U P Mosimann; J Bächli-Biétry; J Boll; I Bopp-Kistler; F Donati; R W Kressig; B Martensson; A U Monsch; R Müri; T Nef; A Rothenberger; R Seeger; A von Gunten; U Wirz
Journal:  Praxis (Bern 1994)       Date:  2012-03-28

5.  Accidents among schizophrenic outpatients.

Authors:  M J Edlund; C Conrad; P Morris
Journal:  Compr Psychiatry       Date:  1989 Nov-Dec       Impact factor: 3.735

6.  Car driving in schizophrenia: can visual memory and organization make a difference?

Authors:  Lena Lipskaya-Velikovsky; Moshe Kotler; Penina Weiss; Maya Kaspi; Shimrit Gamzo; Navah Ratzon
Journal:  Disabil Rehabil       Date:  2013-01-25       Impact factor: 3.033

7.  Driving under the influence (DUI) among patients in opioid maintenance treatment (OMT): a registry-based national cohort study.

Authors:  Anne Bukten; Aina Herskedal; Svetlana Skurtveit; Jørgen G Bramness; Thomas Clausen
Journal:  Addiction       Date:  2013-07-19       Impact factor: 6.526

8.  Neuropsychology of schizophrenia according to Kraepelin: disorders of volition and executive functioning.

Authors:  R F Zec
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

9.  Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trial.

Authors:  Michael Soyka; Martin Lieb; Sabine Kagerer; Christina Zingg; Gabriele Koller; Peter Lehnert; Claudia Limmer; Heinrich Kuefner; Kristina Hennig-Fast
Journal:  J Clin Psychopharmacol       Date:  2008-12       Impact factor: 3.153

10.  BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.

Authors:  A R Lingford-Hughes; S Welch; L Peters; D J Nutt
Journal:  J Psychopharmacol       Date:  2012-05-23       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.